IDX.ASX: Commencement Date for New MD & CEO

Commencement Date for New MD & CEO

Stock	Integral Diagnostics Ltd (IDX.ASX)
Release Time	25 Mar 2026, 9:07 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Integral Diagnostics Announces New MD & CEO Start Date

Key Points

Jason Martinez appointed as new Managing Director and CEO
Commencing role on 6 August 2026 after extended garden leave
Dr Ian Kadish to continue as MD & CEO until transition

Full Summary

Integral Diagnostics Limited (ASX: IDX) has announced the commencement date for its new Managing Director and Chief Executive Officer, Jason Martinez. Mr Martinez was appointed to the role in November 2025, and IDX has now confirmed that he will commence in the position on 6 August 2026, following an extended garden leave period with his former employer. Until Mr Martinez's start date, the current Managing Director and CEO, Dr Ian Kadish, will continue serving in the role to ensure a seamless leadership transition for the company. IDX is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia's leading radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model that ensures quality patient care, service and access.